Clinical studies show that serum apolipoprotein M (ApoM) levels in patients with type 2 diabetes inversely correlate with the progression of diabetic nephropathy, suggesting that ApoM/S1P could help in preventing and mitigating diabetic nephropathy. Here, APOM is linked to type 2 diabetes mellitus.